16 February 2024 – The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have launched two public electronic catalogues: one for real-world data (RWD) sources and another for working draft (WD) studies.

The catalogues help medicines regulators, researchers and pharmaceutical companies in identifying the most suitable data sources to address specific research questions and support the assessment of study protocols and results. They aim to promote transparency, encourage the use of good practices, and build trust in research based on RWD.

For more information, see here.